NewsFeed
Headlines ASRM ESHRE FIGO ACOG Fertility and Sterility PCOS
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Immune Regulation Insights from RaFJC Conference – Reproduction and Fertility
Reproduction and Fertility/LinkedIn
Dec 14, 2025, 04:14

Immune Regulation Insights from RaFJC Conference – Reproduction and Fertility

Reproduction and Fertility shared a post on LinkedIn:

“Day 5 and the final day of RaFJC – Immune Regulation Across Reproduction: From Mechanisms to Therapies

Over the past five days, we’ve explored the immune and inflammatory continuum in reproduction:

During Day 1, we discussed ovulation as an immune-regulated event, with extracellular matrix and cytokine pathways shaping follicle rupture.

On Day 2, we discussed implantation as a form of controlled inflammation that balances tolerance and defense.

On Day 3, we explored how early-pregnancy immune markers (NK CD69, CD57) may predict viability in ART patients.

On Day 4, we theorised about an innovative translational therapy: placenta-targeted nanoparticles for localised immune cloaking in recurrent pregnancy loss.

Today, we synthesise these insights to highlight future directions in reproductive immunology.

Immune balance is central: too much inflammation leads to implantation failure, while too little results in poor tissue remodeling.

Peripheral biomarkers matter: blood-based immune signatures may offer early diagnostic tools for pregnancy outcomes.

Targeted therapies are the future: moving away from systemic immunosuppression toward site-specific immune modulation (e.g., nanoparticles, ligand-based cloaking).

Cost and scalability: innovative therapies must be affordable and manufacturable at scale to reach patients globally.

Immune pathways guide reproduction from ovulation to delivery.

By integrating basic science, clinical diagnostics, and translational therapies, we can:

  • improve fertility treatments
  • reduce miscarriage rates
  • enhance maternal and fetal health outcomes

This continuum underscores the importance of multidisciplinary collaboration between immunologists, clinicians, and translational researchers.

Share your opinion:

  • Which biomarkers should be prioritized for clinical validation?
  • How can we ensure equitable access to emerging therapies?
  • Which collaborations are needed to accelerate translation from the lab to the clinic?”

Reproduction and Fertility

Stay updated on all scientific advances in the field of fertility with Fertility News.

NewsFeed